Please login to the form below

Not currently logged in
Email:
Password:

Cancer Insights

This page shows the latest Cancer Insights news and features for those working in and with pharma, biotech and healthcare.

FDA and Flatiron extend real world evidence collaboration

FDA and Flatiron extend real world evidence collaboration

The FDA's Richard Pazdur. In the first phase of the partnership, Flatiron provided the FDA with de-identified datasets to provide insights on cancer patients with advanced non-small cell ... lung cancer being treated with immunotherapy (see  here and 

Latest news

  • Pharma shares data on cancer projects Pharma shares data on cancer projects

    Cancer Centre in the US - designed to collect cancer research data in a single location. ... Howard Scher, chief of the genitourinary oncology service at Memorial Sloan Kettering Cancer Centre, said the PDS: "will enable the research community to bring

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Oncology drugs under AMNOG: part two Oncology drugs under AMNOG: part two

    Patient-relevant outcomes and the 'added benefit' of cancer drugs. We conclude our look at AMNOG and cancer drugs with some insights from the benefit assessment process and focus on the ... Analysis of decisions on cancer drugs over the past three years

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics